Kezar Life Sciences
123 hedge funds and large institutions have $734M invested in Kezar Life Sciences in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $674M → $734M (+$60.3M)
10% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 41
0.37% less ownership
Funds ownership: 8.22% → 7.85% (-0.37%)
Holders
123
Holding in Top 10
6
Calls
$13.9M
Puts
$4.25M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$15M | |
| 3 | +$9.49M | |
| 4 |
Millennium Management
New York
|
+$8.83M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$7.57M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$4.47M | |
| 3 | -$4.33M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$4.16M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.97M |